Your browser doesn't support javascript.
loading
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer.
Kok, Marleen; Gielen, Robbert-Jan; Adams, Sylvia; Lennerz, Jochen K; Sharma, Priyanka; Loibl, Sibylle; Reardon, Erin; Sonke, Gabe; Linn, Sabine; Delaloge, Suzette; Lacombe, Denis; Robinson, Tim; Badve, Sunil; Martin, Miguel; Balko, Justin M; Ignatiadis, Michail; Curigliano, Giuseppe; Wolff, Antonio C; Mittendorf, Elizabeth A; Loi, Sherene; Pusztai, Lajos; Tolaney, Sara M; Salgado, Roberto.
Afiliação
  • Kok M; Departments of Medical Oncology and Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Gielen RJ; Departments of Medical Oncology and Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Adams S; Perlmutter Cancer Center, NYU Langone Health, New York, NY.
  • Lennerz JK; Department of Medicine, NYU Grossman School of Medicine, Manhattan, NY.
  • Sharma P; BostonGene, Waltham, MA.
  • Loibl S; University of Kansas Medical Center, Westwood, KS.
  • Reardon E; GBG Forschungs GmbH, Neu-Isenburg, Germany.
  • Sonke G; Centre for Haematology and Oncology, Bethanien, and Goethe University, Frankfurt, Germany.
  • Linn S; Physician, Patient.
  • Delaloge S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lacombe D; Departments of Medical Oncology and Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Robinson T; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Badve S; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Martin M; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Balko JM; Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Ignatiadis M; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Emory University Winship Cancer Institute, Atlanta, GA.
  • Curigliano G; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain.
  • Wolff AC; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Mittendorf EA; Breast Medical Oncology Clinic, Institut Jules Bordet, Universite Libre de Bruxelles, Bruxelles, Belgium.
  • Loi S; European Institute of Oncology, IRCCS, Milan, Italy.
  • Pusztai L; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.
  • Tolaney SM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Salgado R; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.
J Clin Oncol ; 42(30): 3523-3529, 2024 Oct 20.
Article em En | MEDLINE | ID: mdl-39038259
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article